CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


NO-ImmunosuppressiveWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (3)


Name (Synonyms) Correlation
drug1184 Immunoglubulins Wiki 1.00
drug1186 Immunosuppressive Wiki 1.00
drug2770 blood test for SARS-COV2 serology Wiki 1.00

Correlated MeSH Terms (2)


Name (Synonyms) Correlation
D003141 Communicable Diseases NIH 0.09
D007239 Infection NIH 0.06

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Effect of Immunosupressive Treatment in COVID-19 Patients Whit SAM-LIKE Profile: Retrospective Cohort Study (SAM-COVID Project)

SAM-COVID is a retrospective cohort study that aims to determine the impact of immunosuppressive drugs and immunoglubulins in the outcome of patients with COVID-19.

NCT04382781 COVID-19 Infection Drug: NO-Immunosuppressive Drug: Immunosuppressive Drug: Immunoglubulins

Primary Outcomes

Description: Days until invasive mechanical ventilation or death, whatever happened first.

Measure: Invasive ventilation or death

Time: Up to 21 days

Secondary Outcomes

Description: Days until mechanical ventilation

Measure: Ventilation

Time: Up to 21 days

Description: Days until death

Measure: Death

Time: Up to 21 days

Description: Proportion of patients developing secondary infections

Measure: Secondary infections

Time: Up to 21 days

Description: Proportion of patients with digestive tract hemorrhage

Measure: Digestive tract hemorrhage

Time: Up to 21 days

Description: Proportion of patients with imnprovement in 2 or more points in 7-point scale by WHO

Measure: Change in 7 points scale

Time: Day 21


No related HPO nodes (Using clinical trials)